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Chloramphenicol muscle residue levels in rainbow trout were determined after oral administration of 
84 μg kg−1d−1 of chloramphenicol for four days. Samples were taken one day before treatment and for 
43 days after the treatment was over. Chloramphenicol was analysed using an in-house enzyme linked 
immunoassay (ELISA) validated against the criteria of the Commission Decision 2002/657/EC. Validation 
parameters confi rmed that the method was appropriate for the detection of chloramphenicol at levels below 
the minimum required performance limit (MRPL) of 0.3 μg kg−1. The highest chloramphenicol levels were 
observed on the fi rst day after the treatment had ended (144.3 μg kg−1). Elimination was signifi cant over the 
fi rst seven days; signifi cant differences were detected between days 1 and 3 (p<0.001), 3 and 5 (p<0.001), 
and 5 and 7 (p<0.05). Chloramphenicol levels dropped below MRPL to 0.17 μg kg−1 on day 9 after the end 
of treatment. From day 11 to 43, chloramphenicol residues were detectable in a range from 0.091 μg kg−1 
(highest) to 0.011 μg kg−1 (lowest). Our results indicate that trout muscle tissue could be compliant with 
health requirements for consumption 10 days after withdrawal from chloramphenicol treatment.
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Chloramphenicol is a broad-spectrum antibiotic 
with well-known bacteriostatic properties effective 
against both gram-positive and gram-negative bacteria, 
as well as against other groups of microorganisms. 
Chloramphenicol binds to the A site of the 
peptidyltransferase centre, where it disturbs the 
placement of A site tRNA and thus prevents peptide 
bond formation (1). Toxicology reports indicate that 
chloramphenicol can cause bone-marrow depression, 
a disorder that is reversible after drug withdrawal. On 
the other hand, chloramphenicol can also cause 
irreversible aplastic anaemia that can result in 
leukaemia (3, 4). Because of these side effects, in 
human medicine chloramphenicol is used when less 
risky drugs are ineffective (2).
Due to risk for human health, the European Union 
has prohibited the use of chloramphenicol in food-
producing animals destined for human consumption 
(5) and set the minimum required performance limit 
(MRPL) to 0.3 μg kg−1 as the minimum content of 
chloramphenicol in several matrices, including 
aquaculture products, to be detected and confi rmed 
by analytical methods (6). However, chloramphenicol 
may still be in use in some developing countries owing 
to its low cost (7, 8). Drug residues have been detected 
in all kinds of animal products imported to the EU, 
especially in honey, shrimp, and other aquatic 
animals such as fi sh, mostly of Asian origin. This 
raises great concern about the impact on consumer 
health.
Viral and bacterial diseases are common in 
aquaculture, especially with high stocking densities. 
In the past, chloramphenicol was used as a 
chemotherapeutic agent to control diseases or as a 
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prophylaxis or disinfectant to prevent disease, either 
through direct application into the aquatic environment 
or through medicated feeds in a mass fraction of (4 
to 8) g per 100 kg (9, 10). Chloramphenicol absorbs 
well in the gastrointestinal tract and its elimination 
half-time varies widely between species. Its lipid 
solubility enables the molecule to persist in most 
tissues, body fl uids, and the central nervous system, 
and it readily diffuses to milk and eggs (11). 
Chloramphenicol residues in aquaculture products 
may present a risk to public health, while residues in 
water and sediment endanger the aquatic environment 
(12).
Rainbow trout is the most cultivated freshwater 
species in aquaculture worldwide. Fish production 
is increasing annually in countries such as Italy, 
France, Germany, Denmark and Spain. Large 
production of fi sh has also been registered in the USA, 
Iran, Germany and the United Kingdom (13). 
However, only a few studies have investigated 
chloramphenicol elimination in fi sh species before 
they reach consumers (14, 15).
The aim of our study was to determine the 
elimination time of chloramphenicol in rainbow 
trout after oral treatment with medicated feed over 
a four-day period using a validated enzyme 
immunoassay method.
MATERIALS AND METHODS
Fish treatment and sampling
Rainbow trout (Oncorhynchus mykiss) were kept 
in 4.7 m3 fi breglass tanks supplied with a constant fl ow 
of 720 L h−1 of water with oxygen content of 
(92.8±3.1) % at a temperature of (9.7±0.1) °C, pH 
(7.5±0.1). The average mass of a trout was (200 to 
250) g, n=200.
For a daily chloramphenicol therapeutic dose of 
84 mg kg-1 d-1, feed (500 g pellets) was added 28 mL 
of chloramphenicol solution (150 mg mL-1; Jiangxi 
Dongxu Chemical Technology Ltd., China) and 
mixed well to achieve homogeneity of the drug 
throughout the matrix. Twice a day the fi sh received 
0.5 kg of medicated pellets per 100 kg of fi sh.
Samples were taken at random one day before 
treatment (baseline), and then on day 1 after 
treatment ended, and on every second (odd) day 
until day 43 (Table 1). On each sampling day, three 
fi sh were taken from a tank, their skin and internal 
organs removed, and muscle tissues and random 
subcutaneous fat partly homogenised, packed in 
plastic bags and stored at -18 °C until analysis.
Reagents and standards
Chloramphenicol kit (type E.G.1) was provided 
by the Laboratory of Hormonology (Marloie, Belgium) 
and consisted of a microtitre plate (96 wells), standard 
solutions of chloramphenicol [(0, 0.05, 0.1, 0.2, 0.5, 
1 and 2) ng mL-1], concentration conjugate (peroxidase 
conjugated chloramphenicol), lyophilised anti-
chloramphenicol antibody, substrate/chromogen 
solution (peroxide/tetramethylbenzidine) dilution 
buffer (pH 7.4), stop solution (6 N H2SO4), and a 
rinsing buffer.
Chloramphenicol standard was from Sigma-
Aldrich (St. Louis, MO, USA). All reagents were of 
analytical, HPLC, or LC-MS grade. Methanol, 
Table 1  Mass fractions of chloramphenicol (mean ± SD, n=3) 
in the muscle of rainbow trout one day before 
(baseline) and for 43 days after the end of treatment 
with doses of 84 mg kg−1 d−1 in medicated feed
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dichloromethane, diethyl ether, and isooctane were 
supplied by Carlo Erba (Milan, Italy).
Nitrogen 5.0 and nitrogen 5.5 were purchased from 
SOL spa (Monza, Italy). Ultra-high purity water was 
processed through a purifi cation system NIRO VV 
UV UF 20 (Nirosta d.o.o. Water Technologies, Osijek, 
Croatia).
Standard stock solutions were prepared on a 
weekly basis by dissolving the analyte in methanol. 
Intermediate working solutions were prepared before 
each analysis by diluting stock solutions in methanol. 
Working solutions were used for spiking blank fi sh 
muscle samples at different levels. Following 
fortifi cation, samples were allowed to equilibrate for 
15 min before extraction.
Sample preparation
A total of 3 g of homogenised fi sh sample was 
weighed and mixed with 3 mL of distilled water. 
Chloramphenicol was extracted from the matrix by 
adding 6 mL of ethyl acetate and mixing with a 
dispersing system for 10 minutes. After centrifugation 
(1006 rpm, 10 min), 5 mL supernatant was taken and 
evaporated with nitrogen until dry at 50 °C. Residues 
were dissolved with 1 mL isooctane/dichloromethane 
mixture (2:3) and mixed intensively with 0.5 mL of 
dissolving buffer (from kit accessories) for 1 min and 
then centrifuged at 1006 rpm for 10 min. If an 
emulsion appeared in the upper layer, residues were 
heated for 2 min in a water bath at 80 °C and 
centrifuged again. For the EIA test, 50 μL of the upper 
layer was used. Immunoassays were performed 
according to the manufacturer’s instructions. The 
absorbance for all assays was measured at 450 nm.
Instrumental
The following instruments were used in sample 
preparation: IKA® Ultra-Turrax® model T25 and IKA® 
Vortex model Genius 3 (IKA® -WERKE GMBH & 
CO.KG, Germany), centrifuge Rotanta 460R (Hettich 
zentrifugen, Tuttlingen, Germany), water bath GFL 
model 1083 (Gesellscaft fur Labortechnik GmbH, 
Burgwedel, Germany), nitrogen evaporation system 
N-EVAP model 111 (Orgamonation Associates Inc., 
Berlin, USA), and a pH meter inoLAB WTW 
(Wilheilm, Germany). The optical density at 450 nm 
was measured by the microplate reader Tecan model 
Sunrise Absorbance Reader (Tecan Austria GmbH, 
Salzburg, Austria).
Validation
Method performance characteristics were 
determined according to the criteria laid down by the 
Commission Decision 2002/657/EC for qualitative 
screening methods (16). The limit of detection (LOD) 
was determined by adding the analyte in quantities 
three and 10 times of 20 mean blank samples. 
Response linearity was calculated from a six-point 
calibration curve [(0.625; 1.25; 2.5; 5; 10) μg kg-1].
Method trueness and precision were determined 
by for t i fying blank muscle  samples  with 
chloramphenicol at (0.15; 0.3; 0.45) μg kg-1 in six 
replicates for each level and analysing them three 
times. The decision limit CCα was evaluated by 
analysing 20 blank milk samples fortifi ed with the 
analyte at the lowest calibration level (0.15 μg kg-1) 
plus 2.33-fold within-laboratory standard deviation 
calculated at this level (n=18). The value of the 
decision limit plus 1.64 times the corresponding 
standard deviation equals detection capability CCβ 
(β=5 %).
Statistical analysis
Analysis of variance was performed using the 
Statistica® 6.1 software package (StatSoft® Inc., Tulsa, 
USA). Results were expressed as mean ± SD. 
Differences in chloramphenicol concentrations 
between days were analysed using Student’s t-test for 
independent pairs. Probability values of ≤0.05 were 
considered statistically signifi cant.
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Table 2  Recovery and accuracy results of ELISA methods used for chloramphenicol determination in trout
Mass fraction / μg kg-1 Recovery / % Standard deviation CV / %Spiked Measured
0.15 0.16 108.4 0.021 10.6
0.3 0.28 92.4 0.024 9.8
0.45 0.35 78.8 0.035 9.5
Mean value 93.2 0.027 9.97
CV - coeffi cient of variation
RESULTS AND DISCUSSION
Elimination of chloramphenicol was estimated 
over 43 days after the end of treatment with 
chloramphenicol in the dose of 84 mg kg-1 day-1. 
Analysis was performed by using enzyme linked 
immunoassay (ELISA) method, in-house validated to 
the criteria of Commission Decision 2002/657/EC. In 
the validation study, the detection capability was 
CCß=0.23 μg kg-1 and the limit of detection (LOD) 
0.0008 μg kg-1. Trueness was expressed in terms of 
recovery (Rec / %) with a mean value of 93.2 % at 
three mass fraction levels (Table 2). The coeffi cient 
of variation (CV / %) for the lowest spiked concentration 
was 10.6 % (<20 %). Validation parameters indicated 
that the method was appropriate for detection of 
chloramphenicol at levels below the MRPL of 
0.3 μg kg-1.
Table 1 shows mean mass fract ions of 
chloramphenicol in the muscle of rainbow trout, on 
baseline and 43 days after the treatment ended. The 
highest chloramphenicol levels were detected on day 
1 after the end of treatment (144.3 μg kg-1). Over the 
next 33 days levels kept dropping from 28.1 μg kg-1 
on day 3 to 0.015 μg kg-1 on day 33. Significant 
elimination took place over the fi rst 7 days after the 
end of treatment, and signifi cant differences were 
detected between days 1 and 3 (p< 0.001), 3 and 5 
(p<0.001), and 5 and 7 (p<0.05). Between days 33 
and 43 after the end of treatment, chloramphenicol 
levels decreased more slowly from 0.015 μg kg-1 to 
0.011 μg kg-1.
In a recent study conducted on rainbow trout 
receiving chloramphenicol in the dose of 73.9 mg
kg-1 d-1 over 10 days (15), mean chloramphenicol level 
was 35.781 μg kg-1 on day 1 after the end of treatment. 
This level is more than 250 times higher than in our 
study and may be due to a 2.5 times longer treatment 
period. Moreover, in that study trout were kept in tanks 
with a constant fl ow of 8 L h-1, as opposed to a 90 
times higher water flow in our study (720 L h-1). 
Accordingly, chloramphenicol levels in our study 
dropped below MRPL of 0.3 μg kg−1 on day 9 
(0.171 μg kg−1) after the end of treatment. In the 
elimination period from day 11 to 43, chloramphenicol 
residues were detectable in the range from a maximum 
of 0.091 μg kg−1 to a minimum of 0.011 μg kg−1. In 
contrast, in the trout treated over 10 days (15), 
chloramphenicol levels were still at 0.3 μg kg-1 31 days 
after the end of treatment.
In a study on shrimp (Penaeus chinensis) receiving 
a diet containing 2000 mg kg-1 of chloramphenicol a 
day over three days, the elimination of chloramphenicol 
to below MRPL took three days (14). It may be 
concluded that withdrawal periods vary widely among 
species (17).
High chloramphenicol mass fractions ranging from 
0.1 μg kg-1 to 34 μg kg-1 were measured in samples of 
aquaculture products in Ireland in 2002 (2). High 
chloramphenicol average of 0.25 μg kg-1, (range: 
0.06 μg kg-1 to 0.69 μg kg-1, with two outlying values 
of 3.0 μg kg-1 and 3.7 μg kg-1) was also confi rmed in 
shrimp samples (2). During the past decade, 
chloramphenicol residues ranging from 0.3 μg kg-1 to 
3.5 μg kg-1 were reported in fi sh and fi sh products 
imported to the EU, mainly from China and Vietnam 
(18). The highest cloramphenicol value of 3.5 μg kg-
1 was measured in Germany in eel imported from 
China. These data confi rm the intentional use of the 
drug in products imported from developing countries 
and call for control of its abuse in aquaculture 
products.
CONCLUSIONS
Our results show that trout tissue could be 
compliant for consumption with no potential risk to 
health after a 10-day withdrawal period.
The method validated and used is very sensitive 
and able to detect chloramphenicol after the fi rst ten 
days after treatment. The method is able to protect 
consumers since it is capable of detecting small 
concentrations of chloramphenicol. Also, if treatment 
with chloramphenicol is not permitted in Europe, the 
use of this method to control fi sh imported from Asian 
Countries should represent a guarantee that fi sh had 
undergone a 10-day withdrawal period.
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Sažetak
ELIMINACIJA KLORAMFENIKOLA U KALIFORNIJSKOJ PASTRVI
Određivani su ostaci kloramfenikola u mišićnom tkivu kalifornijske pastrve nakon oralne primjene u dozi 
od 84 μg kg−1d−1 tijekom 4 dana. Uzorkovanje je provedeno dan prije tretmana te tijekom 43 dana nakon 
tretmana. Maseni udjeli kloramfenikola određivani su primjenom in-house imunoenzimske metode (ELISA) 
validirane prema kriterijima Odluke Komisije 2002/657/EC. Dobiveni validacijski parametri pokazuju da 
je metoda prikladna za određivanje kloramfenikola na nivou manjem od vrijednosti granice najmanje 
zahtijevane učinkovitosti izvedbe metode (MRPL) od 0,3 μg kg−1. Najviši maseni udjeli kloramfenikola 
utvrđeni su prvog dana nakon završetka tretmana (144,3 μg kg−1). Statistički značajna eliminacija utvrđena 
je tijekom sedam dana te je značajno smanjenje određeno između prvog i trećeg (p<0,001), trećeg i petog 
(p<0,001) te petog i sedmog dana nakon tretmana (p<0,05). Razina kloramfenikola ispod MRPL vrijednosti 
utvrđena je devetog dana (0,17 μg kg−1) nakon tretmana. U vremenu od 11. do 43. dana nakon tretmana 
određeni su ostaci kloramfenikola od maksimalno 0,091 μg kg−1 do minimalno 0,011 μg kg−1. Prikazani 
rezultati pokazuju da se 10 dana nakon završetka tretmana tkivo pastrve može smatrati prikladnim za 
konzumaciju bez potencijalne štete za zdravlje.
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